Welcome to LookChem.com Sign In|Join Free

CAS

  • or
H-PRO-GLY-NH2 HCL, also known as N-(2-Hydroxypropyl)glycine hydrochloride, is a chemical compound consisting of the amino acids proline and glycine linked by a peptide bond. It is commonly used in the synthesis of peptides and proteins and is frequently utilized in the field of biochemistry and pharmaceutical research. H-PRO-GLY-NH2 HCL is often employed as a building block in the creation of peptide and protein structures due to its ability to form stable and predictable bond formations. Additionally, the hydrochloride salt form of H-PRO-GLY-NH2 provides enhanced solubility in aqueous solutions, making it suitable for various biochemical applications.

51952-37-5 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 51952-37-5 Structure
  • Basic information

    1. Product Name: H-PRO-GLY-NH2 HCL
    2. Synonyms: H-PRO-GLY-NH2 HCL;H-Pro-Gly-NH2
    3. CAS NO:51952-37-5
    4. Molecular Formula: C7H14ClN3O2
    5. Molecular Weight: 207.66
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 51952-37-5.mol
  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: 500.6°C at 760 mmHg
    3. Flash Point: 256.6°C
    4. Appearance: /
    5. Density: N/A
    6. Vapor Pressure: 2.12E-10mmHg at 25°C
    7. Refractive Index: N/A
    8. Storage Temp.: -15°C
    9. Solubility: N/A
    10. CAS DataBase Reference: H-PRO-GLY-NH2 HCL(CAS DataBase Reference)
    11. NIST Chemistry Reference: H-PRO-GLY-NH2 HCL(51952-37-5)
    12. EPA Substance Registry System: H-PRO-GLY-NH2 HCL(51952-37-5)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 51952-37-5(Hazardous Substances Data)

51952-37-5 Usage

Uses

Used in Biochemistry and Pharmaceutical Research:
H-PRO-GLY-NH2 HCL is used as a building block for the synthesis of peptides and proteins, allowing for the creation of stable and predictable bond formations in peptide and protein structures.
Used in Biochemical Applications:
H-PRO-GLY-NH2 HCL is used as a component in various biochemical applications due to its enhanced solubility in aqueous solutions, which makes it suitable for a wide range of uses in this field.

Check Digit Verification of cas no

The CAS Registry Mumber 51952-37-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,1,9,5 and 2 respectively; the second part has 2 digits, 3 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 51952-37:
(7*5)+(6*1)+(5*9)+(4*5)+(3*2)+(2*3)+(1*7)=125
125 % 10 = 5
So 51952-37-5 is a valid CAS Registry Number.
InChI:InChI=1/C7H13N3O2.ClH/c8-6(11)4-10-7(12)5-2-1-3-9-5;/h5,9H,1-4H2,(H2,8,11)(H,10,12);1H

51952-37-5SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name Prolylglycinamide hydrochloride (1:1)

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:51952-37-5 SDS

51952-37-5Upstream product

51952-37-5Downstream Products

51952-37-5Relevant articles and documents

Synthesis of novel Gn-RH analogues using Ugi-4MCR

Arabanian, Armin,Mohammadnejad, Mahdieh,Balalaie, Saeed,Gross, Jürgen H.

experimental part, p. 887 - 890 (2009/09/06)

An efficient method for the synthesis of some Gn-RH analogues based on Ugi reaction has been developed. Four-component reaction of N- and C-terminus peptides, aromatic aldehydes and isocyanides affords novel Gn-RH analogues derived from triptorelin and go

Process for preparing the releasing hormone of luteinizing hormone (LH) and of follicle stimulating hormone (FSH), salts and compositions thereof, and intermediates therefor

-

, (2008/06/13)

A process for preparing the LH- and FSH-releasing hormone of the formula I which comprises the following steps: Condensing N-(5-oxo-L-prolyl)-L-histidine hydrazide by means of the azide method with L-tryptophan benzyl ester and treating the resulting compound with hydrazine hydrate to obtain N-[N-(5-oxo-L-prolyl)-L-histidyl]-L-tryptophan hydrazide (II); treating N-[O-benzyl-N-carboxy-L-tyrosyl]glycine N-benzyl ester with ethyl chloroformate to obtain the corresponding mixed anhydride which is reacted with t-butyl carbazate to obtain the corresponding 2-carboxyhydrazide t-butyl ester which is hydrogenolyzed to N-L-tyrosylglycine 2-carboxyhydrazide t-butyl ester, and condensing the latter with N-carboxy-L-seryl N-benzyl ester 2,4-dinitrophenyl ester followed by hydrogenolysis of the reaction product to obtain N-(N-L-seryl-L-tyrosyl)glycine 2-carboxyhydrazide t-butyl ester (III); condensing N-carboxy-L-proline N-benzyl ester with glycine ethyl ester in the presence of dicyclohexylcarbodiimide, treating the resulting product with ammonia and then hydrogenolyzing, to obtain 2-[(L-prolyl)amino]acetamide, which is condensed with N-carboxy-NG -nitro-L-arginine N-t-butyl ester in the presence of dicyclohexylcarbodiimide and N-hydroxysuccinimide to obtain N-[N-(N-carboxy-NG -nitro-L-arginyl)-L-prolyl)]glycinamide N-t-butyl ester (IV); or alternatively condensing L-proline methyl ester with N-carboxy-NG -nitro-arginine N-t-butyl ester in the presence of dicyclohexylcarbodiimide, condensing the resulting product with glycine ethyl ester in the presence of dicyclohexylcarbodiimide, and treating the resulting product with ammonia to obtain the same compound IV as above; treating said compound IV with acid and then with N-carboxy-L-leucine N-benzyl ester 2,4,5-trichlorophenyl ester and hydrogenolyzing the resulting product in acetic acid, to obtain N-[N-[N-(N-L-leucyl)-L-arginyl]-L-prolyl]-glycinamide diacetate (V); condensing compound II with compound III by means of the azide method to obtain the hexapeptide N-[N-[N-[N-[N-(5-oxo-L-prolyl)-L-histidyl]-L-tryptophyl]-L-seryl]-L-tyrosyl]glycine 2-carboxyhydrazide t-butyl ester, or condensing N-[N-(5-oxo-L-prolyl)-L-histidyl]-L-tryptophan with compound III in the presence of dicyclohexylcarbodiimide to obtain the same hexapeptide as above, and deprotecting and converting the latter to its trifluoroacetate salt (VI); and condensing compound V with compound VI by means of the azide method, to obtain the decapeptide of formula I which is isolated as the diacetate salt and optionally converted to other pharmaceutically acceptable salts.

Process for preparing the releasing hormone of luteinizing hormone (LH) and of follicle stimulating hormone (FSH), salts and compositions thereof, and intermediates therefor

-

, (2008/06/13)

A process for preparing the LH- and FSH-releasing hormone of the formula I which is isolated as the hydrochloride salt and optionally converted to other pharmaceutically acceptable salts or to pharmaceutically acceptable metal complexes.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 51952-37-5